RecruitingPhase 3NCT05969457

Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach

Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach: Randomized, Double-blind Study


Sponsor

University Hospital, Rouen

Enrollment

108 participants

Start Date

Sep 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The research procedure is the injection of 20 mL of Ropivacaine solution (vs. saline) to create a paracervical block at the beginning of surgery, while the patient is already under general anesthesia. This injection will take place 3 minutes before the vaginal incision, via 4 injection points. Injections are made 3 mm deep into the vaginal cul de sac. Randomization takes place before surgery by vNOTES: * Experienced group: Local anesthesia with injection of Ropivacaine (20mL of ropivacaine 7.5 mg/mL, i.e. 150mg) and general anesthesia * Control group: Injection of 20mL of placebo (saline) and general anesthesia In both groups, systematic intraoperative and postoperative analgesia will be identical.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years

Inclusion Criteria4

  • Adult patients aged 18 to 70 inclusive
  • Patient scheduled for vNOTES surgery for total hysterectomy for benign pathology, whether or not associated with an adnexal procedure (unilateral or bilateral salpingectomy or adnexectomy (for cysts smaller than 6 cm)).
  • Person having read and understood the information letter and signed the consent form
  • Person affiliated to a social security scheme

Exclusion Criteria12

  • Suspicion of malignant pathology
  • History of rectal surgery
  • History of pelvic inflammatory disease
  • Suspicion of recto-vaginal endometriosis
  • Virginity
  • Contraindication to NAROPEINE 7.5 mg/mL, solution for injection in ampoule
  • Contraindication to PROAMP SODIUM CHLORIDE 0.9%, solution for injection
  • Patients on a low-salt diet
  • History of more than 2 caesarean sections
  • Estimated uterine size > 700 g according to the following formula y = 0.35x + 107 (x = a × b × c), based on measurements taken on preoperative imaging (MRI or ultrasound). a=longitudinal diameter, b=sagital diameter, c=transverse diameter.3
  • BMI > 35
  • Contraindication to analgesic molecules in intraoperative and postoperative protocols.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNaropeine

Local anesthesia with injection of Ropivacaine (20mL of ropivacaine 7.5 mg/mL, i.e. 150mg)

OTHERquestionnaires

Numerical Rating scale Questionnaire FSFI Qustionnaire SF12 Questionnaire DN4

OTHERPlacebo

Injection of 20 mL of NaCl


Locations(2)

Gh Le Havre

Le Havre, France

Chu Rouen

Rouen, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05969457